Development of new anticoagulant in 2023: Prime time for anti-factor XI and XIa inhibitors
Nûn K. Bentounes, Sophie Melicine, A. Martin, David M. Smadja, Nicolas Gendron
Topics & Concepts
MedicineHemostasisFondaparinuxIntensive care medicineThrombosisWarfarinArgatrobanDiscovery and development of direct thrombin inhibitorsAnticoagulantAtrial fibrillationInternal medicineVenous thromboembolismThrombinPlateletCoagulation, Bradykinin, Polyphosphates, and AngioedemaBlood Coagulation and Thrombosis MechanismsUrticaria and Related Conditions